NCT04670575View on ClinicalTrials.gov

Vivity Outcomes in Patients With Early Stage Glaucoma

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

October 31, 2022

Study Completion Date

November 30, 2022

Conditions
GlaucomaCataractPresbyopia
Interventions
PROCEDURE

Cataract Surgery with Implantation of Vivity Extended Range of Vision IOL

Patients with early stage glaucoma implanted with Vivity or Vivity Toric IOL

Trial Locations (1)

57108

Vance Thompson Vision, Sioux Falls

All Listed Sponsors
lead

Vance Thompson Vision

OTHER

NCT04670575 - Vivity Outcomes in Patients With Early Stage Glaucoma | Biotech Hunter | Biotech Hunter